The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term ...

New Alzheimer's drugs slow cognitive decline by 27% but cause dangerous brain swelling in 40% of patients, sparking medical debate over risk versus benefit.

New trial finds liraglutide reduces brain shrinkage by nearly 50% in Alzheimer’s patients and slows cognitive decline by up to 18% ...

The holidays can be especially tough for those facing Alzheimer’s. Experts say early diagnosis is key, with new treatments offering hope and more time with family.

A new study has thrown a spanner in the works regarding a treatment widely prescribed to women over 50. Hormone replacement therapy (HRT), used to relieve menopausal symptoms, may actually increase ...

In a little over ten years, organoid models—miniature, lab-grown clusters of cells that imitate real organs—have transformed how we study human development and disease while accelerating drug ...

Memory care operators are moving from simply providing “good caregiving” to creating a data-rich environment that allows for ...

A year of new treatments, new technologies, new ways to stay safe during disasters and new insights on the mysteries of the ...

Pfizer deals again in obesity space as Wave and Structure drop splashy weight loss results; what CDER Director Richard Pazdur’s sudden retirement means for biopharma; neuro diseases take center stage ...

During the latest instalment, they touched upon how the programme's One Million Minutes campaign went on the road.